Skip to main content

Cell and gene therapy based approaches for treatment of Parkinson's disease: from models to clinics

Objective

Parkinson s disease is one of the common causes of disability in the aging population, representing a major health problem for the affected individuals and a socioeconomic burden to the society. In the present proposal, the applicant puts forward an ambitious but feasible program to tackle a number of significant issues that remain unsolved in the field. He combines his strong track record in animal models of Parkinson s disease and novel cell and gene therapy-based therapeutic strategies with powerful bio-imaging techniques in order to make bold steps towards translation of new and better treatments to patients suffering from this illness. He does so in a manner that combines, on one hand, the strength of clearly-defined hypotheses and well-established tools for results towards clinical translation, with high-risk high-reward projects that hold the potential to yield ground-breaking discoveries in implementation of novel imaging techniques, on the other.

Call for proposal

ERC-2009-StG
See other projects for this call

Host institution

MAX IV Laboratory, Lund University
Address
Paradisgatan 5c
22100 Lund
Sweden

See on map

Activity type
Higher or Secondary Education Establishments
Principal investigator
Deniz Kirik (Prof.)
Administrative Contact
Deniz Kirik (Prof.)
EU contribution
€ 1 508 940

Beneficiaries (1)

MAX IV Laboratory, Lund University
Sweden
EU contribution
€ 1 508 940
Address
Paradisgatan 5c
22100 Lund

See on map

Activity type
Higher or Secondary Education Establishments
Principal investigator
Deniz Kirik (Prof.)
Administrative Contact
Deniz Kirik (Prof.)